Mumbai, India

Yogesh Shejul

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Impetis Biosciences Limited. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yogesh Shejul. Retrieved from https://idiyas.com/inventor/yogesh-shejul-lojj4rdg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Mumbia, IN (2022)
  • Mumbai, IN (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yogesh Shejul - Revolutionizing Technology in Mumbai

Introduction: Yogesh Shejul is a visionary inventor based in Mumbai, India, known for his groundbreaking contributions to the field of technology.

Latest Patents: Yogesh Shejul holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Yogesh Shejul has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Yogesh Shejul has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge sharing to drive progress in the tech sector.

Conclusion: Yogesh Shejul's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field, inspiring the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…